ETFs positioned on Kenvue Inc.

Name Weight AuM 1st Jan change Investor Rating
0.09% 42 M€ +27.29% -
0.07% 26 M€ +16.85% -
0.06% 1,166 M€ +0.26% -
0.06% 607 M€ -0.19%
0.01% 15 M€ -1.62% -
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (41,8%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (29.9%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (28.3%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49.3%), Europe-Middle East-Africa (21.9%), Asia-Pacific (20.1%) and Latin America (8.7%).
Employees
22,000
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
surperformance-ratings-light-chart KENVUE-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
22.22USD
Average target price
24.82USD
Spread / Average Target
+11.72%
Consensus

Quarterly revenue - Rate of surprise